FOR IMMEDIATE RELEASE

 

Contact:                 Gregory Guest

                                (973) 564-7555

                                marketing@drg-international.com

  

DRG® Aldosterone ELISA Kit at the 2018 AACC (Booth# 3438)

- Diagnostic and Research product manufacturer to showcase ELISA kit which differentiates between primary and secondary Aldosteronism -

Newswise — Springfield, New Jersey, USA (July 2018)— DRG International, a leading international medical diagnostic company, will showcase its DRG® Aldosterone ELISA Kit at the 2018 AACC Conference in Chicago, Illinois from July 29 – August 2.  The DRG International Aldosterone ELISA is for measurement of Aldosterone in serum, plasma, and urine.

Aldosterone regulates levels of sodium and potassium in the body and also controls blood pressure as well as fluids and electrolytes in the blood.  Measurement of aldosterone levels in serum in conjunction with plasma renin levels (aldosterone/renin-ratio; ARR) can be used to differentiate between primary and secondary aldosteronism. The differentiation is vital in the treatment and management of the disease.

“The importance of testing Aldosterone is growing in the research and clinical communities,” said Dr. Matthias Herkert, Senior Scientist of DRG Instruments Gmbh.  “The accuracy and ease of use of this kit make it a top choice of researchers world-wide.”

The DRG® Aldosterone ELISA Kit (EIA-5298R) is an exciting addition to the laboratory field. It is a solid phase enzyme-linked immunosorbent assay (ELISA) based on the competitive principle. The Aldosterone ELISA Kit is available globally, and for research use only in the United States.

DRG International will be showcasing at the AACC in Booth-3438.  Press inquiries are welcome. For more information, please contact Gregory Guest (Marketing Manager for DRG International) at (973) 564-7555.


~*~

 

DRG International, Inc. founded in 1970, is a multinational specialty medical equipment and diagnostics manufacturer and distributor with successful operations in over 110 countries.

DRG supplies an extensive line of immunodiagnostic products including fertility and pregnancy tests, endocrinology/diabetes, saliva hormone diagnostics, tumor markers, infectious diseases, immunology/hematology, thyroid function panels, cardiovascular assays as well as therapeutic and toxicology screening products. To obtain more information about the DRG group of companies and complete product line, please visit our New website at:  www.drg-international.com